Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.23M Buy
5,192
+3,548
+216% +$3.63M 1.55% 13
2026
Q1
$1.51M Buy
1,644
+415
+34% +$421K 1.41% 18
2025
Q4
$1.32M Buy
+1,229
New +$1.18M 1.29% 20
2025
Q2
$824K Sell
1,057
-858
-45% -$667K 0.82% 31
2025
Q1
$1.58M Buy
1,915
+410
+27% +$341K 1.03% 25
2024
Q4
$1.16M Sell
1,505
-43
-3% -$35.6K 0.75% 32
2024
Q3
$1.37M Buy
1,548
+102
+7% +$91.7K 0.92% 25
2024
Q2
$1.31M Buy
1,446
+141
+11% +$113K 0.94% 25
2024
Q1
$1.01M Buy
+1,305
New +$929K 0.77% 37

Other funds holding LLY

Wealth Group's LLY Position: Q2 2026 in Review

Wealth Group increased its Eli Lilly (LLY) stake by 216% in Q2 2026, buying an estimated $3.63M and bringing the position to 5,192 shares worth $6.23M. The position accounts for 1.55% of the portfolio, ranked #13.

Wealth Group first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Group held 5,192 shares of Eli Lilly worth $6.23M as of Q2 2026.
  • Wealth Group bought 3,548 Eli Lilly shares in Q2 2026, an estimated $3.63M.
  • Eli Lilly made up 1.55% of Wealth Group's portfolio in Q2 2026, its #13 holding.
  • Wealth Group first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.